Swedish HealthTech startup Epigenica raises €1.8 million to
study changes in gene expression
Stockholm-based Epigenica AB, announced today that it has closed a €1.8 million round to fuel its growth and commercial expansion across key markets.
Read the article on EU Startups >
Read More from the Global Wellness News ™